Benjamin Bonavida

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vega Mario I; Martínez-Paniagua Melisa; Huerta-Yepez Sara; González-Bonilla Cesar; Uematsu Norio; Bonavida Benjamin
Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.
Vega Mario I; Huerta-Yepez Sara; Martinez-Paniagua Melisa; Martinez-Miguel Bernardo; Hernandez-Pando Rogelio; González-Bonilla Cesar R; Chinn Paul; Hanna Nabil; Hariharan Kandasamy; Jazirehi Ali R; Bonavida Benjamin
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Baritaki Stavroula; Yeung Kam; Palladino Michael; Berenson James; Bonavida Benjamin
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Benjamin Bonavida (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vega Mario I; Martínez-Paniagua Melisa; Huerta-Yepez Sara; González-Bonilla Cesar; Uematsu Norio; Bonavida Benjamin
Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.
International journal of oncology 2009;35(6):1289-96.
2009: Vega Mario I; Huerta-Yepez Sara; Martinez-Paniagua Melisa; Martinez-Miguel Bernardo; Hernandez-Pando Rogelio; González-Bonilla Cesar R; Chinn Paul; Hanna Nabil; Hariharan Kandasamy; Jazirehi Ali R; Bonavida Benjamin
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(21):6582-94.
2009: Baritaki Stavroula; Yeung Kam; Palladino Michael; Berenson James; Bonavida Benjamin
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
Cancer research 2009;69(21):8376-85.
2009: Baritaki S; Chapman A; Yeung K; Spandidos D A; Palladino M; Bonavida B
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
Oncogene 2009;28(40):3573-85.
2009: Sieber Sebastian; Gdynia Georg; Roth Wilfried; Bonavida Benjamin; Efferth Thomas
Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate.
International journal of oncology 2009;35(1):149-58.
2009: Zaravinos Apostolos; Kanellou Peggy; Baritaki Stavroula; Bonavida Benjamin; Spandidos Demetrios A
BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma.
Cell cycle (Georgetown, Tex.) 2009;8(9):1402-8.
2009: Huerta Sergio; Baay-Guzman Guillermina; Gonzalez-Bonilla Cesar R; Livingston Edward H; Huerta-Yepez Sara; Bonavida Benjamin
In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2009;20(3):182-94.
2009: Baritaki Stavroula; Chatzinikola Anthoula M; Vakis Antonios F; Soulitzis Nikolaos; Karabetsos Dimitris A; Neonakis Ioannis; Bonavida Benjamin; Spandidos Demetrios A
YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels.
Cancer investigation 2009;27(2):184-92.
2009: Chen Haiming; Campbell Richard A; Chang Yunchao; Li Mingjie; Wang Cathy S; Li Jennifer; Sanchez Eric; Share Michael; Steinberg Jeffrey; Berenson Ariana; Shalitin Dror; Zeng Zhaohui; Gui Dorina; Perez-Pinera Pablo; Berenson Ronald J; Said Jonathan; Bonavida Benjamin; Deuel Thomas F; Berenson James R
Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.
Blood 2009;113(9):1992-2002.
2009: Huerta-Yepez Sara; Vega Mario; Escoto-Chavez Saul E; Murdock Benjamin; Sakai Toshiyuki; Baritaki Stavroula; Bonavida Benjamin
Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2009;20(1):39-52.
2009: Ortiz-Sánchez E; Daniels T R; Helguera G; Martinez-Maza O; Bonavida B; Penichet M L
Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(1):59-70.
2009: Yoon Nam K; Seligson David B; Chia David; Elshimali Yahya; Sulur Giri; Li Ai; Horvath Steve; Maresh Erin; Mah Vei; Bose Shikha; Bonavida Benjamin; Goodglick Lee
Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
Cancer biomarkers : section A of Disease markers 2009;5(4):215-24.
2009: Wu Katherine; Bonavida Benjamin
The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Critical reviews in immunology 2009;29(3):241-54.
2009: Katsman Alina; Umezawa Kazuo; Bonavida Benjamin
Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ.
Current pharmaceutical design 2009;15(7):792-808.
2008: Huerta Sergio; Chilka Sapna; Bonavida Benjamin
Nitric oxide donors: novel cancer therapeutics (review).
International journal of oncology 2008;33(5):909-27.
2008: Vega Mario I; Martinez-Paniagua Melissa; Jazirehi Ali R; Huerta-Yepez Sara; Umezawa Kazuo; Martinez-Maza Otoniel; Bonavida Benjamin
The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs.
Leukemia & lymphoma 2008;49(10):1982-94.
2008: Bonavida Benjamin; Baritaki Stavroula; Huerta-Yepez Sara; Vega Mario I; Chatterjee Devasis; Yeung Kam
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2008;19(2):152-7.
2008: Li Zhi-Wei; Chen Haiming; Campbell Richard A; Bonavida Benjamin; Berenson James R
NF-kappaB in the pathogenesis and treatment of multiple myeloma.
Current opinion in hematology 2008;15(4):391-9.
2008: Baritaki Stavroula; Suzuki Eriko; Umezawa Kazuo; Spandidos Demetrios A; Berenson James; Daniels Tracy R; Penichet Manuel L; Jazirehi Ali R; Palladino Michael; Bonavida Benjamin
Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):6199-210.
2008: Bilir Ayhan; Erguven Mine; Oktem Gulperi; Ozdemir Aysegul; Uslu Atilla; Aktas Esin; Bonavida Benjamin
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
International journal of oncology 2008;32(4):829-39.
2007: Seligson David B; Hongo Fumiya; Huerta-Yepez Sara; Mizutani Yoichi; Miki Tsuneharu; Yu Hong; Horvath Steve; Chia David; Goodglick Lee; Bonavida Benjamin
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6056-63.
2007: Baritaki Stavroula; Katsman Alina; Chatterjee Devasis; Yeung Kam C; Spandidos Demetrios A; Bonavida Benjamin
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):5441-53.
2007: Lee Ji Yeun; Huerta-Yepez Sara; Vega Mario; Baritaki Stavroula; Spandidos Demetrios A; Bonavida Benjamin
The NO TRAIL to YES TRAIL in cancer therapy (review).
International journal of oncology 2007;31(4):685-91.
2007: Huerta Sergio; Heinzerling John H; Anguiano-Hernandez Yu-Mei; Huerta-Yepez Sara; Lin Jeffrey; Chen David; Bonavida Benjamin; Livingston Edward H
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
The Journal of surgical research 2007;142(1):184-94.
2007: Suzuki E; Umezawa K; Bonavida B
Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
Oncogene 2007;26(42):6184-93.
2007: Campbell Richard A; Sanchez Eric; Steinberg Jeffrey A; Baritaki Stavroula; Gordon Melinda; Wang Cathy; Shalitin Dror; Chen Haiming; Pang Shen; Bonavida Benjamin; Said Jonathan; Berenson James R
Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
British journal of haematology 2007;138(4):467-78.
2007: Baritaki Stavroula; Sifakis Stavros; Huerta-Yepez Sara; Neonakis Ioannis K; Soufla Giannoula; Bonavida Benjamin; Spandidos Demetrios A
Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
International journal of oncology 2007;31(1):69-79.
2007: Chen Haiming; Gordon Melinda S; Campbell Richard A; Li Mingjie; Wang Cathy S; Lee Hee Jin; Sanchez Eric; Manyak Steven J; Gui Dorina; Shalitin Dror; Said Jonathan; Chang Yunchao; Deuel Thomas F; Baritaki Stavroula; Bonavida Benjamin; Berenson James R
Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth.
Blood 2007;110(1):287-95.
2007: Bonavida B
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.
Oncogene 2007;26(25):3629-36.
2007: Baritaki Stavroula; Huerta-Yepez Sara; Sakai Toshiyuki; Spandidos Demetrios A; Bonavida Benjamin
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Molecular cancer therapeutics 2007;6(4):1387-99.
2007: Mizutani Yoichi; Nakanishi Hiroyuki; Li Yong Nan; Matsubara Hiroki; Yamamoto Kosuke; Sato Nodoka; Shiraishi Takumi; Nakamura Terukazu; Mikami Kazuya; Okihara Koji; Takaha Natsuki; Ukimura Osamu; Kawauchi Akihiro; Nonomura Norio; Bonavida Benjamin; Miki Tsuneharu
Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
International journal of oncology 2007;30(4):919-25.
2007: Katsman Alina; Umezawa Kazuo; Bonavida Benjamin
Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(1-2):1-12.
2007: Jazirehi Ali R; Vega Mario I; Bonavida Benjamin
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
Cancer research 2007;67(3):1270-81.
2007: Baritaki Stavroula; Apostolakis Stavros; Kanellou Peggy; Dimanche-Boitrel Marie-Therese; Spandidos Demetrios A; Bonavida Benjamin
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications.
Advances in cancer research 2007;98():149-90.
2006: Akopyan Gohar; Bonavida Benjamin
Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.
International journal of oncology 2006;29(4):745-52.
2006: Ng Patrick P; Helguera Gustavo; Daniels Tracy R; Lomas Simon Z; Rodriguez Jose A; Schiller Gary; Bonavida Benjamin; Morrison Sherie L; Penichet Manuel L
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Blood 2006;108(8):2745-54.
2006: Chen H; Li M; Campbell R A; Burkhardt K; Zhu D; Li S G; Lee H J; Wang C; Zeng Z; Gordon M S; Bonavida B; Berenson J R
Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Oncogene 2006;25(49):6520-7.
2006: Huerta-Yepez Sara; Vega Mario; Garban Hermes; Bonavida Benjamin
Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Clinical immunology (Orlando, Fla.) 2006;120(3):297-309.
2006: Bonavida Benjamin; Khineche Soraya; Huerta-Yepez Sara; Garbán Hermes
Therapeutic potential of nitric oxide in cancer.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2006;9(3):157-73.
2006: Campbell Richard A; Manyak Steven J; Yang Honghao H; Sjak-Shie Nelida N; Chen Haiming; Gui Dorina; Popoviciu Laura; Wang Cathy; Gordon Melinda; Pang Shen; Bonavida Benjamin; Said Jonathan; Berenson James R
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma.
International journal of oncology 2006;28(6):1409-17.
2006: Yeh Howard S; Chen Haiming; Manyak Steven J; Swift Regina A; Campbell Richard A; Wang Cathy; Li Mingjie; Lee Hee Jin; Waterman Gabriel; Gordon Melinda S; Ma Jonathan; Bonavida Benjamin; Berenson James R
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status.
British journal of haematology 2006;133(5):526-9.
2006: Schumacher Lana Y; Vo Dan D; Garban Hermes J; Comin-Anduix Begoña; Owens Sharla K; Dissette Vivian B; Glaspy John A; McBride William H; Bonavida Benjamin; Economou James S; Ribas Antoni
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).
Journal of immunology (Baltimore, Md. : 1950) 2006;176(8):4757-65.
2006: Gordon S; Akopyan G; Garban H; Bonavida B
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.
Oncogene 2006;25(8):1125-42.
2005: Vega Mario I; Huerta-Yepez Sara; Jazirehi Ali R; Garban Hermes; Bonavida Benjamin
Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Oncogene 2005;24(55):8114-27.
2005: Bonavida B; Huerta-Yepez S; Goodglick L; Mizutani Y; Miki T
Can we develop biomarkers that predict response of cancer patients to immunotherapy?
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2005;10 Suppl 1():S69-76.
2005: Hongo Fumiya; Garban Hermes; Huerta-Yepez Sara; Vega Mario; Jazirehi Ali R; Mizutani Yoichi; Miki Tsuneharu; Bonavida Benjamin
Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Biochemical and biophysical research communications 2005;336(2):692-701.
2005: Vega Mario I; Jazirehi Ali R; Huerta-Yepez Sara; Bonavida Benjamin
Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(4):2174-83.
2005: Seligson David; Horvath Steve; Huerta-Yepez Sara; Hanna Stephanie; Garban Hermes; Roberts Alice; Shi Tao; Liu Xueli; Chia David; Goodglick Lee; Bonavida Benjamin
Expression of transcription factor Yin Yang 1 in prostate cancer.
International journal of oncology 2005;27(1):131-41.
2005: Jazirehi Ali R; Bonavida Benjamin
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Oncogene 2005;24(13):2121-43.
2005: Bonavida Benjamin; Vega Mario I
Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2005;8(1-2):27-41.
2005: Jazirehi Ali R; Huerta-Yepez Sara; Cheng Genhong; Bonavida Benjamin
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Cancer research 2005;65(1):264-76.
2005: Mizutani Yoichi; Nakanishi Hiroyuki; Yamamoto Kosuke; Li Yong Nan; Matsubara Hiroki; Mikami Kazuya; Okihara Koji; Kawauchi Akihiro; Bonavida Benjamin; Miki Tsuneharu
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):448-54.
2004: Jazirehi Ali R; Vega Mario I; Chatterjee Devasis; Goodglick Lee; Bonavida Benjamin
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Cancer research 2004;64(19):7117-26.
2004: Mizutani Yoichi; Matsubara Hiroki; Yamamoto Kosuke; Nan Li Yong; Mikami Kazuya; Okihara Koji; Kawauchi Akihiro; Bonavida Benjamin; Miki Tsuneharu
Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Cancer 2004;101(8):1794-802.
2004: Whiting David; Hsieh George; Yun James J; Banerji Anamika; Yao William; Fishbein Michael C; Belperio John; Strieter Robert M; Bonavida Benjamin; Ardehali Abbas
Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(12):7417-24.
2004: Huerta-Yepez Sara; Vega Mario; Jazirehi Ali; Garban Hermes; Hongo Fumiya; Cheng Genhong; Bonavida Benjamin
Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Oncogene 2004;23(29):4993-5003.
2004: Vega Mario I; Huerta-Yepaz Sara; Garban Hermes; Jazirehi Ali; Emmanouilides Christos; Bonavida Benjamin
Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.
Oncogene 2004;23(20):3530-40.
2004: Jazirehi Ali R; Bonavida Benjamin
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Molecular cancer therapeutics 2004;3(1):71-84.
2004: Odabaei Golaun; Chatterjee Devasis; Jazirehi Ali R; Goodglick Lee; Yeung Kam; Bonavida Benjamin
Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.
Advances in cancer research 2004;91():169-200.
2003: Jazirehi Ali R; Gan Xiao-Hu; De Vos Sven; Emmanouilides Christos; Bonavida Benjamin
Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
Molecular cancer therapeutics 2003;2(11):1183-93.
2003: Fischbein Michael P; Yun James; Laks Hillel; Irie Yoshihito; Oslund-Pinderski Laura; Fishbein Michael C; Bonavida Benjamin; Ardehali Abbas
Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts.
The Journal of thoracic and cardiovascular surgery 2003;126(1):216-23.
2003: Hansch Corwin; Jazirehi Ali; Mekapati Suresh Babu; Garg Rajni; Bonavida Benjamin
QSAR of apoptosis induction in various cancer cells.
Bioorganic & medicinal chemistry 2003;11(13):3015-9.
2003: Gan Xiao-Hu; Zhang Ling; Heber David; Bonavida Benjamin
Mechanism of activation of human peripheral blood NK cells at the single cell level by Echinacea water soluble extracts: recruitment of lymphocyte-target conjugates and killer cells and activation of programming for lysis.
International immunopharmacology 2003;3(6):811-24.
2003: Cal C; Garban H; Jazirehi A; Yeh C; Mizutani Y; Bonavida B
Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Current medicinal chemistry. Anti-cancer agents 2003;3(2):77-93.
2003: Huerta Sergio; Harris Diane M; Jazirehi Ali; Bonavida Benjamin; Elashoff David; Livingston Edward H; Heber David
Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis.
International journal of oncology 2003;22(3):663-70.
2003: Hansch Corwin; Bonavida Benjamin; Jazirehi Ali R; Cohen J John; Milliron Cheri; Kurup Alka
Quantitative structure-activity relationships of phenolic compounds causing apoptosis.
Bioorganic & medicinal chemistry 2003;11(4):617-20.
2003: Frost Patrick; Caliliw Randy; Belldegrun Arie; Bonavida Benjamin
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
International journal of oncology 2003;22(2):431-7.
2003: Alas Steve; Bonavida Benjamin
Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):316-26.
2002: Emmanouilides Christos; Jazirehi Ali R; Bonavida Benjamin
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):621-30.
2002: Ng Chuen-Pei; Zisman Amnon; Bonavida Benjamin
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
The Prostate 2002;53(4):286-99.
2002: Ng Chuen-Pei; Bonavida Benjamin
X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Molecular cancer therapeutics 2002;1(12):1051-8.
2002: Mizutani Yoichi; Yoshida Osamu; Ukimura Osamu; Kawauchi Akihiro; Bonavida Benjamin; Miki Tsuneharu
Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer.
Cancer biotherapy & radiopharmaceuticals 2002;17(5):563-7.
2002: Gan Xiaohu; Zhang Ling; Solomon George F; Bonavida Benjamin
Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Brain, behavior, and immunity 2002;16(3):227-46.
2002: Fischbein Michael P; Yun James; Laks Hillel; Irie Yoshihito; Fishbein Michael C; Bonavida Benjamin; Ardehali Abbas
Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.
The Journal of thoracic and cardiovascular surgery 2002;123(4):803-9.
2002: Mori Shunsuke; Murakami-Mori Kaoru; Nakamura Shuji; Bonavida Benjamin
Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
International journal of oncology 2002;20(4):819-26.
2002: Alas Steve; Ng Chuen-Pei; Bonavida Benjamin
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):836-45.
2002: Mizutani Yoichi; Wada Hiromi; Yoshida Osamu; Fukushima Masakazu; Bonavida Benjamin; Kawauchi Akihiro; Miki Tsuneharu
Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
Oncology reports 2002;9(2):289-92.
2002: Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
European journal of cancer (Oxford, England : 1990) 2002;38(1):167-76.
2002: Ng Chuen-Pei; Bonavida Benjamin
A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance.
Advances in cancer research 2002;85():145-74.
2001: Jazirehi A R; Ng C P; Gan X H; Schiller G; Bonavida B
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3874-83.
2001: Alas S; Bonavida B
Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
Cancer research 2001;61(13):5137-44.
2001: Keith Bechtel M; Bonavida B
Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase.
Gynecologic oncology 2001;82(1):127-38.
2001: Garbán H J; Bonavida B
Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(1):75-81.
2001: Fischbein M P; Yun J; Laks H; Irie Y; Fishbein M C; Espejo M; Bonavida B; Ardehali A
CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
Transplantation 2001;71(8):1146-53.
2001: Alas S; Emmanouilides C; Bonavida B
Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):709-23.
2001: Frost P J; Butterfield L H; Dissette V B; Economou J S; Bonavida B
Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3564-73.
2001: Garbán H J; Bonavida B
Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha -induced cytotoxicity.
The Journal of biological chemistry 2001;276(12):8918-23.
2001: Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
The Journal of urology 2001;165(1):263-70.
2000: Fischbein M P; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein M C; Bonavida B
CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7316-22.
2000: Alas S; Bonavida B; Emmanouilides C
Potentiation of fludarabine cytotoxicity on non-Hodgkin's lymphoma by pentoxifylline and rituximab.
Anticancer research 2000;20(5A):2961-6.
2000: Jewett A; Bonavida B
MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
Clinical immunology (Orlando, Fla.) 2000;96(1):19-28.
2000: Frost P; Bonavida B
Circumvention of tumor cell escape following specific immunotherapy.
Cancer biotherapy & radiopharmaceuticals 2000;15(2):141-52.
2000: Itakura M; Mori S; Park N H; Bonavida B
Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
International journal of oncology 2000;16(3):591-7.
2000: Murakami-Mori K; Mori S; Bonavida B
Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: growth and apoptosis.
Advances in cancer research 2000;78():159-97.
1999: Bonavida B; Ng C P; Jazirehi A; Schiller G; Mizutani Y
Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review).
International journal of oncology 1999;15(4):793-802.
1999: Frost P J; Belldegrun A; Bonavida B
Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
The Prostate 1999;41(1):20-30.
1999: Garbán H J; Bonavida B
Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.
Gynecologic oncology 1999;73(2):257-64.
1999: Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(9):5616-23.
1999: Gan X H; Bonavida B
Preferential induction of TNF-alpha and IL-1beta and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic aza-alkyl lysophospholipids.
Cellular immunology 1999;193(2):125-33.
1999: Mori S; Murakami-Mori K; Bonavida B
Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells.
Biochemical and biophysical research communications 1999;257(2):609-14.
1999: Mori S; Murakami-Mori K; Bonavida B
Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Anticancer research 1999;19(2A):1011-5.
1999: Murakami-Mori K; Mori S; Bonavida B; Nakamura S
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3672-9.
1999: Cavalcanti M; Jewett A; Bonavida B
Irreversible cancer cell-induced functional anergy and apoptosis in resting and activated NK cells.
International journal of oncology 1999;14(2):361-6.
1998: Mori S; Murakami-Mori K; Bonavida B
Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Anticancer research 1998;18(6A):4403-8.
1998: Mori S; Jewett A; Cavalcanti M; Murakami-Mori K; Nakamura S; Bonavida B
Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin.
International journal of oncology 1998;12(5):1165-70.
1997: Jewett A; Cavalcanti M; Bonavida B
Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):4815-22.
1997: Frost P; Ng C P; Belldegrun A; Bonavida B
Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
Cellular immunology 1997;180(1):70-83.
1997: Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
Cancer immunology, immunotherapy : CII 1997;44(5):282-90.
1997: Demidem A; Lam T; Alas S; Hariharan K; Hanna N; Bonavida B
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs.
Cancer biotherapy & radiopharmaceuticals 1997;12(3):177-86.
1997: Uslu R; Borsellino N; Frost P; Gárban H; Ng C P; Mizutani Y; Belldegrun A; Bonavida B
Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):963-72.
1997: Jewett A; Cavalcanti M; Giorgi J; Bonavida B
Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(11):5492-500.
1996: Uslu R; Jewett A; Bonavida B
Sensitization of human ovarian tumor cells by subtoxic CDDP to anti-fas antibody-mediated cytotoxicity and apoptosis.
Gynecologic oncology 1996;62(2):282-91.
1996: Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
Cancer research 1996;56(8):1874-9.
1996: Uslu R; Bonavida B
Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Cancer 1996;77(4):725-32.
1996: Jewett A; Bonavida B
Target-induced inactivation and cell death by apoptosis in a subset of human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):907-15.
1996: Jewett A; Gan X H; Lebow L T; Bonavida B
Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.
Journal of clinical immunology 1996;16(1):46-54.
1995: Hu P F; Hultin L E; Hultin P; Hausner M A; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi J V
Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(3):331-40.
1995: Borsellino N; Belldegrun A; Bonavida B
Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
Cancer research 1995;55(20):4633-9.
1995: Jewett A; Bonavida B
Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset.
Cellular immunology 1995;160(1):91-7.
1995: Jewett A; Bonavida B
Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
Journal of clinical immunology 1995;15(1):35-44.
1995: Hober D; Jewett A; Bonavida B
Lysis of uninfected HIV-1 gp120-coated peripheral blood-derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicity.
FEMS immunology and medical microbiology 1995;10(2):83-91.
1995: Vredevoe D L; Moser D K; Gan X H; Bonavida B
Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine.
Neuroimmunomodulation 1995;2(1):16-24.
1994: Gan X H; Robin J P; Huerta J M; Braquet P; Bonavida B
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative.
Journal of clinical immunology 1994;14(5):280-8.
1994: Jewett A; Bonavida B
Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Cellular immunology 1994;154(1):273-86.
1994: Bonavida B; Braquet M; Lebow L T; Jewett A
Qualitative and quantitative analysis of subpopulations of cytotoxic effector cells by flow cytometry.
Journal of lipid mediators and cell signalling 1994;9(1):19-25.
1994: Jewett A; Bonavida B
Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion.
Journal of clinical immunology 1994;14(1):31-8.
1994: Bonavida B; Mencia-Huerta J M
Platelet-activating factor and the cytokine network in inflammatory processes.
Clinical reviews in allergy 1994;12(4):381-95.
1993: Jewett A; Bonavida B
Pivotal role of endogenous TNF-alpha in the IL-2-driven activation and proliferation of the functionally immature NK free subset.
Cellular immunology 1993;151(2):257-69.
1993: Mizutani Y; Bonavida B
Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
Cancer 1993;72(3):809-18.
1993: Bonavida B; Lebow L T; Jewett A
Natural killer cell subsets: maturation, differentiation and regulation.
Natural immunity 1993;12(4-5):194-208.
1993: Morimoto H; Yonehara S; Bonavida B
Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
Cancer research 1993;53(11):2591-6.
1993: Safrit J T; Belldegrun A; Bonavida B
Sensitivity of human renal cell carcinoma lines to TNF, adriamycin, and combination: role of TNF mRNA induction in overcoming resistance.
The Journal of urology 1993;149(5):1202-8.
1993: Safrit J T; Berek J S; Bonavida B
Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Gynecologic oncology 1993;48(2):214-20.
1993: Lebow L T; Jewett A; Bonavida B
Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):320-9.
1993: Morimoto H; Principe P; Robin J P; Broquet C; Mencia-Huerta J M; Braquet P; Bonavida B
Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines.
Cancer chemotherapy and pharmacology 1993;32(4):293-300.
1993: Mizutani Y; Bonavida B
Pentoxifylline enhances sensitivity of a human ovarian cancer cell line (OVC-8) to TNF-alpha.
Biotherapy (Dordrecht, Netherlands) 1993;7(2):109-14.
1992: Safrit J T; Bonavida B
Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance.
Cancer research 1992;52(23):6630-7.
1992: Morimoto H; Bonavida B
Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(6):2089-94.
1992: Gan X H; Jewett A; Bonavida B
Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.
Natural immunity 1992;11(3):144-55.
1992: Safrit J T; Bonavida B
Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.
Cancer immunology, immunotherapy : CII 1992;34(5):321-8.
1991: Morimoto H; Broquet C; Principe P; Mencia-Huerta J M; Braquet P; Bonavida B
Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.
Anticancer research 1991;11(6):2223-9.
1991: Morimoto H; Safrit J T; Bonavida B
Synergistic effect of tumor necrosis factor-alpha- and diphtheria toxin-mediated cytotoxicity in sensitive and resistant human ovarian tumor cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(8):2609-16.
1991: Bonavida B
Immunomodulatory effect of tumor necrosis factor.
Biotherapy (Dordrecht, Netherlands) 1991;3(2):127-33.
1990: Jewett A; Giorgi J V; Bonavida B
Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(12):4065-71.
1990: Bonavida B; Tsuchitani T; Zighelboim J; Berek J S
Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Gynecologic oncology 1990;38(3):333-9.
1990: Lebow L T; Bonavida B
Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(16):6063-7.
1990: Nio Y; Zighelboim J; Berek J S; Bonavida B
Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
Anticancer research 1990;10(2A):441-6.
1990: Jewett A; Bonavida B
Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
Clinical immunology and immunopathology 1990;54(2):192-9.
1990: Nio Y; Zighelboim J; Berek J S; Bonavida B
Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
Natural immunity and cell growth regulation 1990;9(4):283-96.
1990: Bonavida B; Mencia-Huerta J M; Braquet P
Effects of platelet-activating factor on peripheral blood monocytes: induction and priming for TNF secretion.
Journal of lipid mediators 1990;2 Suppl():S65-76.
1989: Bonavida B; Jewett A
Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
Cellular immunology 1989;123(2):373-83.
1989: Chang M P; Bramhall J; Graves S; Bonavida B; Wisnieski B J
Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition.
The Journal of biological chemistry 1989;264(26):15261-7.
1989: Katz J D; Lebow L T; Bonavida B
The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(4):1387-95.
1989: Nio Y; Zighelboim J; Berek J; Bonavida B
Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells.
Cancer 1989;64(2):434-41.
1989: Hasegawa Y; Bonavida B
Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(8):2670-6.
1989: Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Progress in clinical and biological research 1989;308():485-9.
1989: Bonavida B; Mencia-Huerta J M; Braquet P
Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.
International archives of allergy and applied immunology 1989;88(1-2):157-60.
1988: Katz J D; Nishanian P; Mitsuyasu R; Bonavida B
Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells.
Journal of clinical immunology 1988;8(6):453-8.
1988: Katz J D; Ohnishi K; Lebow L T; Bonavida B
The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
The Journal of experimental medicine 1988;168(5):1553-62.
1988: Baldwin R L; Chang M P; Bramhall J; Graves S; Bonavida B; Wisnieski B J
Capacity of tumor necrosis factor to bind and penetrate membranes is pH-dependent.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2352-7.
1988: Wright S C; Jewett A; Mitsuyasu R; Bonavida B
Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):99-104.
1988: Nio Y; Zighelboim J; Berek J S; Bonavida B
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.
Cancer immunology, immunotherapy : CII 1988;27(3):246-54.
1988: Zighelboim J; Nio Y; Berek J S; Bonavida B
Immunologic control of ovarian cancer.
Natural immunity and cell growth regulation 1988;7(4):216-25.
1987: Katz J D; Mitsuyasu R; Gottlieb M S; Lebow L T; Bonavida B
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(1):55-60.
1987: Ohnishi K; Bonavida B
RCS tumor-host interactions: tumor growth dependence on L3T4+ T cells and its regulation by suppressor cells.
Progress in clinical and biological research 1987;244():359-68.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Benjamin Bonavida

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Phenomena

Procedures

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Benjamin Bonavida (preview)

All Publications